Valtech specializes in the development of technologically advanced, clinically proven devices for mitral and tricuspid valve repair and replacement, and thus offering physicians and their patients safer and more effective alternatives to current valvular treatments. In 2016, Valtech was purchased by Edwards Lifesciences.
We have been with Valtech from its inception, throughout its sale to Edwards Lifesciences. We created company’s visual language and strategy around the company’s innovative technology. We implemented the new brand language into company’s responsive website, corporate presentations and exhibitions.